Equipping Computational Pathology Systems with Artifact Processing Pipelines: A Showcase for Computation and Performance Trade-offs
Neel Kanwal, Farbod Khoraminia, Umay Kiraz, Andres Mosquera-Zamudio, Carlos Monteagudo, Emiel A. M. Janssen, Tahlita C. M. Zuiverloon, Chunmig Rong, Kjersti Engan
TL;DR
This work tackles the detrimental impact of histological artifacts on CPATH by introducing a Mixture of Experts (MoE) approach and multiclass baselines to detect five artifacts in WSIs. The MoE framework trains five binary experts (one per artifact) and fuses their outputs with a meta-threshold $t_s$ to maximize artifact-free sensitivity, while also providing artifact segmentation and QC outputs. Evaluations on internal EMC_dev data and external OoD cohorts show that DCNN-based MoE offers the best overall performance, albeit with higher computational cost, whereas multiclass models provide faster inference with a modest performance trade-off. The proposed artifact-processing pipeline yields segmentation maps, artifact reports, artifact-free ROI masks, and artifact-free WSIs, enabling more reliable CPATH predictions and built-in quality control across diverse tissue types and scanners.
Abstract
Histopathology is a gold standard for cancer diagnosis under a microscopic examination. However, histological tissue processing procedures result in artifacts, which are ultimately transferred to the digitized version of glass slides, known as whole slide images (WSIs). Artifacts are diagnostically irrelevant areas and may result in wrong deep learning (DL) algorithms predictions. Therefore, detecting and excluding artifacts in the computational pathology (CPATH) system is essential for reliable automated diagnosis. In this paper, we propose a mixture of experts (MoE) scheme for detecting five notable artifacts, including damaged tissue, blur, folded tissue, air bubbles, and histologically irrelevant blood from WSIs. First, we train independent binary DL models as experts to capture particular artifact morphology. Then, we ensemble their predictions using a fusion mechanism. We apply probabilistic thresholding over the final probability distribution to improve the sensitivity of the MoE. We developed DL pipelines using two MoEs and two multiclass models of state-of-the-art deep convolutional neural networks (DCNNs) and vision transformers (ViTs). DCNNs-based MoE and ViTs-based MoE schemes outperformed simpler multiclass models and were tested on datasets from different hospitals and cancer types, where MoE using DCNNs yielded the best results. The proposed MoE yields 86.15% F1 and 97.93% sensitivity scores on unseen data, retaining less computational cost for inference than MoE using ViTs. This best performance of MoEs comes with relatively higher computational trade-offs than multiclass models. The proposed artifact detection pipeline will not only ensure reliable CPATH predictions but may also provide quality control.
